Loss of asthma control after cessation of omalizumab treatment: real life data
Authors:
- Izabela Kupryś-LipińskaIKIzabela Kupryś-Lipińska
- Piotr KunaPKPiotr Kuna
- 1 January 2014
- journal article
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 1, 1-5
Abstract
Introduction: Many clinical and observational studies have demonstrated effectiveness of omalizumab (OMA) in the treatment of severe asthma, but the optimal duration of the therapy remains unknown. Aim: The article presents the authors’ clinical experience on OMA cessation in routine...Keywords
This publication has 15 references indexed in Scilit:
- Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma controlRespiratory Medicine, 2014
- State of the art paper Asthma: beyond corticosteroid treatmentArchives of Medical Science, 2013
- Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-upTherapeutic Advances in Respiratory Disease, 2012
- State of the art paper Therapeutic options for severe asthmaArchives of Medical Science, 2012
- [The analysis of the factors influencing the development of glucocorticoid resistance in the etiopathogenesis of severe bronchial asthma].2010
- After 6 years with Xolair; a 3‐year withdrawal follow‐upAllergy, 2009
- Omalizumab, Recombinant Humanized Monoclonal Antibody Anti-IgE—New Fields of Studies on the Therapeutic IndicationsAdvances in Respiratory Medicine, 2008
- Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapyJournal of Allergy and Clinical Immunology, 2008
- Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthmaJournal of Allergy and Clinical Immunology, 2004
- [Epidemics of allergic diseases: a new health problem in the modern world].2003